Medical Decisions, Estrogen and Aging
Autor Jay Schulkinen Limba Engleză Paperback – 19 oct 2010
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 695.89 lei 6-8 săpt. | |
SPRINGER NETHERLANDS – 19 oct 2010 | 695.89 lei 6-8 săpt. | |
Hardback (1) | 704.22 lei 6-8 săpt. | |
SPRINGER NETHERLANDS – 21 dec 2007 | 704.22 lei 6-8 săpt. |
Preț: 695.89 lei
Preț vechi: 732.51 lei
-5% Nou
Puncte Express: 1044
Preț estimativ în valută:
133.22€ • 138.48$ • 110.46£
133.22€ • 138.48$ • 110.46£
Carte tipărită la comandă
Livrare economică 05-19 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789048176991
ISBN-10: 9048176999
Pagini: 196
Ilustrații: XVI, 178 p.
Dimensiuni: 155 x 235 x 10 mm
Greutate: 0.28 kg
Ediția:Softcover reprint of hardcover 1st ed. 2008
Editura: SPRINGER NETHERLANDS
Colecția Springer
Locul publicării:Dordrecht, Netherlands
ISBN-10: 9048176999
Pagini: 196
Ilustrații: XVI, 178 p.
Dimensiuni: 155 x 235 x 10 mm
Greutate: 0.28 kg
Ediția:Softcover reprint of hardcover 1st ed. 2008
Editura: SPRINGER NETHERLANDS
Colecția Springer
Locul publicării:Dordrecht, Netherlands
Public țintă
Professional/practitionerCuprins
Hormone Therapy: Biological, Social, and Medical Context.- Demythologized Human Decision-Making.- Autonomic Regulation, Heart, and Strokes.- Bad News—Good News: Cancers and Bone.- Brain, Mood, and Cognition.- Physicians' and Women's Responses to HT Findings: Implications for Continuous Learning and Self-Corrective Inquiry for Physicians.
Textul de pe ultima copertă
The decision-making process that underlies ovarian hormone therapy (HT) is a fallible one. The question is whether or not physicians should prescribe HT to menopausal women, who are at a time in their lives when they are factoring various concerns into their decision to take (or not take) HT. Not only is it difficult to determine whether or not to prescribe HT, but what kind; should physicians recommend estrogen or progestin, or another combination of related hormones? The decision of whether or not to use HT has affected, and will continue to affect, many women in the United States and throughout the world and is an important model elucidating the forces that influence medical decision-making.
Two recent large-scale studies, one conducted here in the United States (the Women’s Health Initiative) and the other in Great Britain (the Million Women Study), were highly publicized and cast a negative light on the use of HT. Since HT’s inception, views have oscillated, due in part to expectations of benefits extending over the course of long-term use beyond the peri-menopausal period, and perhaps due to the overselling of research investigating the efficacy of HT. Thus, the decision for women to go on HT remains a controversial issue, and the decision-making process is undermined further by overzealous advertising and an exaggerated understanding of the research results (both positive and negative).
This book is unique in that it integrates core findings from within the Decision Sciences and Evidence Based Medicine in light of the research that has been done on HT. Medical Decisions, Estrogen and Aging integrates the various components that go into medical decision making in the context of understanding the dilemmas that surround HT. Therefore this book is intended for both specialists and generalists in the field, and it is ideally suited for use by graduate and medical students, medical health care professionals, behavioralscientists, medical ethicists, gerontologists, historians of science, and endocrinologists.
Two recent large-scale studies, one conducted here in the United States (the Women’s Health Initiative) and the other in Great Britain (the Million Women Study), were highly publicized and cast a negative light on the use of HT. Since HT’s inception, views have oscillated, due in part to expectations of benefits extending over the course of long-term use beyond the peri-menopausal period, and perhaps due to the overselling of research investigating the efficacy of HT. Thus, the decision for women to go on HT remains a controversial issue, and the decision-making process is undermined further by overzealous advertising and an exaggerated understanding of the research results (both positive and negative).
This book is unique in that it integrates core findings from within the Decision Sciences and Evidence Based Medicine in light of the research that has been done on HT. Medical Decisions, Estrogen and Aging integrates the various components that go into medical decision making in the context of understanding the dilemmas that surround HT. Therefore this book is intended for both specialists and generalists in the field, and it is ideally suited for use by graduate and medical students, medical health care professionals, behavioralscientists, medical ethicists, gerontologists, historians of science, and endocrinologists.
Caracteristici
Written for both specialists and generalists in the field Bridges diverse features that surround the decision-making concerning hormone therapy